iNtRON Biotechnology Inc (048530) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.013x

Based on the latest financial reports, iNtRON Biotechnology Inc (048530) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-993.53 Million ≈ $-673.30K USD) by net assets (₩73.98 Billion ≈ $50.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see iNtRON Biotechnology Inc (048530) market capitalisation for the company's overall valuation and market capitalisation.

iNtRON Biotechnology Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how iNtRON Biotechnology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

iNtRON Biotechnology Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of iNtRON Biotechnology Inc ranked by their cash flow conversion efficiency. Explore 048530 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Farmsco KO:036580	0.097x
HSS Engineers Bhd KLSE:0185	-0.057x
BranchOut Food Inc. Common Stock NASDAQ:BOF	-0.624x
Madusari Murni Indah Tbk PT JK:MOLI	0.036x
Nurol Gayrimenkul Yatirim Ortakligi AS IS:NUGYO	0.016x
Noble Development Public Company Limited BK:NOBLE	0.074x
Thai Wacoal Public Company Limited BK:WACOAL	-0.002x
Wspierania Przedsiebiorczosci WAR:PTW	0.003x

Annual Cash Flow Conversion Efficiency for iNtRON Biotechnology Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of iNtRON Biotechnology Inc from 2012 to 2024. View 048530 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩83.77 Billion ≈ $56.77 Million	₩-138.47 Million ≈ $-93.84K	-0.002x	-105.13%
2023-12-31	₩96.73 Billion ≈ $65.56 Million	₩3.12 Billion ≈ $2.11 Million	0.032x	-42.74%
2022-12-31	₩106.18 Billion ≈ $71.96 Million	₩5.98 Billion ≈ $4.05 Million	0.056x	-65.37%
2021-12-31	₩101.35 Billion ≈ $68.68 Million	₩16.47 Billion ≈ $11.16 Million	0.163x	+94.60%
2020-12-31	₩85.38 Billion ≈ $57.86 Million	₩7.13 Billion ≈ $4.83 Million	0.084x	+767.82%
2019-12-31	₩64.96 Billion ≈ $44.02 Million	₩-812.48 Million ≈ $-550.61K	-0.013x	-111.64%
2018-12-31	₩39.09 Billion ≈ $26.49 Million	₩4.20 Billion ≈ $2.85 Million	0.107x	+159.44%
2017-12-31	₩30.24 Billion ≈ $20.50 Million	₩-5.47 Billion ≈ $-3.71 Million	-0.181x	-91.32%
2016-12-31	₩49.15 Billion ≈ $33.31 Million	₩-4.64 Billion ≈ $-3.15 Million	-0.094x	-291.53%
2015-12-31	₩34.44 Billion ≈ $23.34 Million	₩1.70 Billion ≈ $1.15 Million	0.049x	+277.79%
2012-12-31	₩11.93 Billion ≈ $8.08 Million	₩-331.01 Million ≈ $-224.32K	-0.028x	--

About iNtRON Biotechnology Inc

KQ:048530 Korea Biotechnology

Market Cap

$60.63 Million

₩89.47 Billion KRW

Market Cap Rank

#21248 Global

#1235 in Korea

Share Price

₩2830.00

Change (1 day)

-4.07%

52-Week Range

₩2330.00 - ₩6650.00

All Time High

₩46250.00